Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 153

1.

Acute podocyte vascular endothelial growth factor (VEGF-A) knockdown disrupts alphaVbeta3 integrin signaling in the glomerulus.

Veron D, Villegas G, Aggarwal PK, Bertuccio C, Jimenez J, Velazquez H, Reidy K, Abrahamson DR, Moeckel G, Kashgarian M, Tufro A.

PLoS One. 2012;7(7):e40589. doi: 10.1371/journal.pone.0040589. Epub 2012 Jul 13.

2.

Induction of podocyte-derived VEGF ameliorates podocyte injury and subsequent abnormal glomerular development caused by puromycin aminonucleoside.

Ma J, Matsusaka T, Yang HC, Zhong J, Takagi N, Fogo AB, Kon V, Ichikawa I.

Pediatr Res. 2011 Jul;70(1):83-9. doi: 10.1203/PDR.0b013e31821bdf1c.

3.

Overexpression of VEGF-A in podocytes of adult mice causes glomerular disease.

Veron D, Reidy KJ, Bertuccio C, Teichman J, Villegas G, Jimenez J, Shen W, Kopp JB, Thomas DB, Tufro A.

Kidney Int. 2010 Jun;77(11):989-99. doi: 10.1038/ki.2010.64. Epub 2010 Mar 10.

4.

Integrin beta1-mediated matrix assembly and signaling are critical for the normal development and function of the kidney glomerulus.

Kanasaki K, Kanda Y, Palmsten K, Tanjore H, Lee SB, Lebleu VS, Gattone VH Jr, Kalluri R.

Dev Biol. 2008 Jan 15;313(2):584-93. Epub 2007 Nov 12.

5.

Podocyte-specific VEGF-a gain of function induces nodular glomerulosclerosis in eNOS null mice.

Veron D, Aggarwal PK, Velazquez H, Kashgarian M, Moeckel G, Tufro A.

J Am Soc Nephrol. 2014 Aug;25(8):1814-24. doi: 10.1681/ASN.2013070752. Epub 2014 Feb 27.

6.

Induction of podocyte VEGF164 overexpression at different stages of development causes congenital nephrosis or steroid-resistant nephrotic syndrome.

Veron D, Reidy K, Marlier A, Bertuccio C, Villegas G, Jimenez J, Kashgarian M, Tufro A.

Am J Pathol. 2010 Nov;177(5):2225-33. doi: 10.2353/ajpath.2010.091146. Epub 2010 Sep 9.

7.

GIV/girdin links vascular endothelial growth factor signaling to Akt survival signaling in podocytes independent of nephrin.

Wang H, Misaki T, Taupin V, Eguchi A, Ghosh P, Farquhar MG.

J Am Soc Nephrol. 2015 Feb;26(2):314-27. doi: 10.1681/ASN.2013090985. Epub 2014 Jul 10.

8.

Necl-5/poliovirus receptor interacts with VEGFR2 and regulates VEGF-induced angiogenesis.

Kinugasa M, Amano H, Satomi-Kobayashi S, Nakayama K, Miyata M, Kubo Y, Nagamatsu Y, Kurogane Y, Kureha F, Yamana S, Hirata K, Miyoshi J, Takai Y, Rikitake Y.

Circ Res. 2012 Mar 2;110(5):716-26. doi: 10.1161/CIRCRESAHA.111.256834. Epub 2012 Jan 26.

9.

Inducible overexpression of sFlt-1 in podocytes ameliorates glomerulopathy in diabetic mice.

Ku CH, White KE, Dei Cas A, Hayward A, Webster Z, Bilous R, Marshall S, Viberti G, Gnudi L.

Diabetes. 2008 Oct;57(10):2824-33. doi: 10.2337/db08-0647. Epub 2008 Jul 22.

10.

Autocrine VEGF-A system in podocytes regulates podocin and its interaction with CD2AP.

Guan F, Villegas G, Teichman J, Mundel P, Tufro A.

Am J Physiol Renal Physiol. 2006 Aug;291(2):F422-8. Epub 2006 Apr 4.

11.

Glomerular structure and function require paracrine, not autocrine, VEGF-VEGFR-2 signaling.

Sison K, Eremina V, Baelde H, Min W, Hirashima M, Fantus IG, Quaggin SE.

J Am Soc Nephrol. 2010 Oct;21(10):1691-701. doi: 10.1681/ASN.2010030295. Epub 2010 Aug 5. Erratum in: J Am Soc Nephrol. 2011 Jul;22(7):1390.

12.

Semaphorin3a disrupts podocyte foot processes causing acute proteinuria.

Tapia R, Guan F, Gershin I, Teichman J, Villegas G, Tufro A.

Kidney Int. 2008 Mar;73(6):733-40. Epub 2007 Dec 12.

13.

Regulation of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF-A) expression in podocytes.

Datta K, Li J, Karumanchi SA, Wang E, Rondeau E, Mukhopadhyay D.

Kidney Int. 2004 Oct;66(4):1471-8.

14.

Vascular endothelial growth factor a signaling in the podocyte-endothelial compartment is required for mesangial cell migration and survival.

Eremina V, Cui S, Gerber H, Ferrara N, Haigh J, Nagy A, Ema M, Rossant J, Jothy S, Miner JH, Quaggin SE.

J Am Soc Nephrol. 2006 Mar;17(3):724-35. Epub 2006 Jan 25.

15.

Excess podocyte semaphorin-3A leads to glomerular disease involving plexinA1-nephrin interaction.

Reidy KJ, Aggarwal PK, Jimenez JJ, Thomas DB, Veron D, Tufro A.

Am J Pathol. 2013 Oct;183(4):1156-1168. doi: 10.1016/j.ajpath.2013.06.022. Epub 2013 Aug 14.

16.

Glomerular VEGF resistance induced by PKCĪ“/SHP-1 activation and contribution to diabetic nephropathy.

Mima A, Kitada M, Geraldes P, Li Q, Matsumoto M, Mizutani K, Qi W, Li C, Leitges M, Rask-Madsen C, King GL.

FASEB J. 2012 Jul;26(7):2963-74. doi: 10.1096/fj.11-202994. Epub 2012 Apr 12.

17.

Effects of high glucose and TGF-beta1 on the expression of collagen IV and vascular endothelial growth factor in mouse podocytes.

Iglesias-de la Cruz MC, Ziyadeh FN, Isono M, Kouahou M, Han DC, Kalluri R, Mundel P, Chen S.

Kidney Int. 2002 Sep;62(3):901-13.

18.

Vascular endothelial growth factor receptor 2 direct interaction with nephrin links VEGF-A signals to actin in kidney podocytes.

Bertuccio C, Veron D, Aggarwal PK, Holzman L, Tufro A.

J Biol Chem. 2011 Nov 18;286(46):39933-44. doi: 10.1074/jbc.M111.241620. Epub 2011 Sep 21.

19.

Crim1KST264/KST264 mice implicate Crim1 in the regulation of vascular endothelial growth factor-A activity during glomerular vascular development.

Wilkinson L, Gilbert T, Kinna G, Ruta LA, Pennisi D, Kett M, Little MH.

J Am Soc Nephrol. 2007 Jun;18(6):1697-708. Epub 2007 Apr 25.

20.

Mesenchymal stem cells ameliorate podocyte injury and proteinuria in a type 1 diabetic nephropathy rat model.

Wang S, Li Y, Zhao J, Zhang J, Huang Y.

Biol Blood Marrow Transplant. 2013 Apr;19(4):538-46. doi: 10.1016/j.bbmt.2013.01.001. Epub 2013 Jan 4.

Supplemental Content

Support Center